"Deoxyguanine Nucleotides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Guanine nucleotides which contain deoxyribose as the sugar moiety.
| Descriptor ID |
D003848
|
| MeSH Number(s) |
D03.633.100.759.646.454.200 D13.695.201.175 D13.695.667.454.200
|
| Concept/Terms |
Deoxyguanine Nucleotides- Deoxyguanine Nucleotides
- Nucleotides, Deoxyguanine
- Deoxyguanosine Phosphates
- Phosphates, Deoxyguanosine
|
Below are MeSH descriptors whose meaning is more general than "Deoxyguanine Nucleotides".
Below are MeSH descriptors whose meaning is more specific than "Deoxyguanine Nucleotides".
This graph shows the total number of publications written about "Deoxyguanine Nucleotides" by people in this website by year, and whether "Deoxyguanine Nucleotides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Deoxyguanine Nucleotides" by people in Profiles.
-
Persistent damaged bases in DNA allow mutagenic break repair in Escherichia coli. PLoS Genet. 2017 Jul; 13(7):e1006733.
-
Removal of 8-oxo-GTP by MutT hydrolase is not a major contributor to transcriptional fidelity. Nucleic Acids Res. 2014 Oct 29; 42(19):12015-26.
-
Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2013 Aug; 13(4):458-66.
-
Pharmacology and mechanism of action of forodesine, a T-cell targeted agent. Semin Oncol. 2007 Dec; 34(6 Suppl 5):S8-12.
-
Purine Nucleosidase Phosphorylase (PNP): A novel target in leukemias and lymphomas. Semin Oncol. 2007 Dec; 34(6 Suppl 5):S1-2.
-
A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine). Blood. 2005 Dec 15; 106(13):4253-60.
-
Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leuk Res. 2003 Dec; 27(12):1077-83.
-
Incorporation of dITP or 7-deaza dGTP during PCR improves sequencing of the product. Nucleic Acids Res. 1993 Sep 11; 21(18):4427-8.